Panebianco, Concetta
Pisati, Federica
Villani, Annacandida
Andolfo, Annapaola
Ulaszewska, Marynka
Bellini, Edoardo http://orcid.org/0000-0001-9766-7685
Ferro, Carmelapia
Lombardi, Renato
Orsenigo, Fabrizio
Latiano, Tiziana Pia
Belmonte, Beatrice
Tripodo, Claudio http://orcid.org/0000-0002-0821-6231
Perri, Francesco
Pazienza, Valerio http://orcid.org/0000-0002-3492-1153
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 2019 - ID. 23006 project)
Ministero della Salute (Ricerca Corrente Program 2022-2024)
Article History
Received: 19 October 2022
Revised: 28 February 2023
Accepted: 3 March 2023
First Online: 5 April 2023
Competing interests
: All the authors declare that they have no competing interests. PV is the founder of PharmaBiotiX.
: All mouse-related experiments were carried out in accordance with the 3Rs rules and guidelines of the Institutional Animal Care and Use Committee of Italian Ministry of Health.
: Informed consent was obtained from pertinent patients for sample and data use in research.